Search results
Wall Street Analysts See a 133.85% Upside in Evolus, Inc. (EOLS): Can the Stock Really Move This...
Zacks via Yahoo Finance· 4 months agoThe consensus price target hints at a 133.9% upside potential for Evolus, Inc. (EOLS). While...
Evolus, Inc. (NASDAQ:EOLS) is a favorite amongst institutional investors who own 56%
Simply Wall St. via Yahoo Finance· 8 months agoKey Insights Significantly high institutional ownership implies Evolus' stock price is sensitive to...
Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 16 hours agoEvolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript May 7, 2024 Evolus, Inc. misses on...
Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 1 day agoEvolus (EOLS) delivered earnings and revenue surprises of -85.71% and 0.95%, respectively, for the...
Evolus (NASDAQ:EOLS) rallies 16% this week, taking three-year gains to 161%
Simply Wall St. via Yahoo Finance· 12 months agoIt might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its...
Investors in Evolus (NASDAQ:EOLS) have seen splendid returns of 135% over the past three years
Simply Wall St. via Yahoo Finance· 7 months agoEvolus, Inc. (NASDAQ:EOLS) shareholders might be concerned after seeing the share price drop 15% in...
The 15% return this week takes Evolus' (NASDAQ:EOLS) shareholders one-year gains to 59%
Simply Wall St. via Yahoo Finance· 6 days agoThese days it's easy to simply buy an index fund, and your returns should (roughly) match the...
Institutional investors own a significant stake of 39% in Evolus, Inc. (NASDAQ:EOLS)
Simply Wall St. via Yahoo Finance· 1 year agoTo get a sense of who is truly in control of Evolus, Inc. (NASDAQ:EOLS), it is important to...
11 Best Low Price Pharma Stocks To Invest In
Insider Monkey via Yahoo Finance· 3 weeks agoIn this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want...
Evolus Insider Ups Holding By 210% During Year
Simply Wall St. via Yahoo Finance· 3 months agoInsiders were net buyers of Evolus, Inc.'s (NASDAQ:EOLS ) stock during the past year. That is, insiders bought more stock than they sold. While insider...
